Cardiac resynchronization therapy with defibrillator (CRT-D) can help certain patients with non-left bundle branch block (non-LBBB) with heart failure if traditional, implantable cardioverter ...

May 11, 2005 (New Orleans) — Poor renal function and the nonuse of certain heart failure medications were powerful predictors of early and late mortality in patients receiving cardiac ...

Patients with dyssynchronous yet viable ventricles are most likely to benefit from cardiac resynchronization therapy combined with defibrillation, concludes the latest analysis of the MADIT CRT trial.

June 2, 2010 (Berlin, Germany) — It didn't come as a shocker, but it's nice to be a little surer of it: cardiac resynchronization therapy (CRT) improves clinical outcomes in appropriately selected ...

AMSTERDAM, the Netherlands—Among patients with heart failure with reduced ejection fraction (HFrEF), a previously implanted pacemaker or ICD, and a significant RV pacing burden, upgrading to a cardiac ...

Cardiac resynchronization therapy (CRT) can restore normal cardiac function in patients with left ventricular dysfunction and an extended QRS duration. The 7-year follow-up of patients with mild heart ...

Amsterdam, Netherlands – 26 Aug 2023: Upgrade to cardiac resynchronisation therapy with a defibrillator (CRT-D) reduces morbidity and mortality and improves left ventricular (LV) reverse remodelling ...

Home telemonitoring is equally effective in ICD and CRT-D patients, a trial has shown. The study's conclusion: "The take home message for clinicians is that if you have a patient with advanced heart ...

Upgrade to cardiac resynchronization therapy with a defibrillator (CRT-D) reduces morbidity and mortality and improves left ventricular (LV) reverse remodeling compared to an implantable ...

ST. PAUL, Minn. -- St. Jude Medical, Inc., a global medical device company, today announced CE Mark approval of its next-generation quadripolar device, the Quadra Assura MP™ cardiac resynchronization ...

The ENDURALIFE battery technology (Boston Scientific) is designed to extend the battery life of Boston Scientific cardiac resynchronisation therapy-defibrillator (CRT‑D) devices. CRT‑Ds are a ...

PLATINIUM, released simultaneously in both Europe and Japan by LivaNova (formerly Sorin Group), will protect patients from avoidable replacement surgeries and the inherent risk of complications.